A multicentre survey of antimicrobial resistance in Gram-negative isolates from Belgian intensive care units in 1994-1995

Acta Clinica Belgica

Volumn 53, Issue 1, 1998, Pages 28-38

  Glupczynski, Y ^a   Delmee M ^b   Goossens, H ^c   Struelens, M ^d   Bardiaux, C ^e   Garrino, M G ^f   Magerman, K ^g   Melin, P ^h   Mertens, H J ⁱ   Meunier, F ^j   Pauquay, J L ^k   Surmont, I ^l   Vael, C ^m   Verbist, L ⁿ   Ursi, J P ^o   Wautelet, J ^p  

^a UNIVERSITY HOSPITAL OF MONT GODINNE   (Belgium)

^b CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^c UNIVERSITY OF ANTWERP   (Belgium)

^d UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^e Centre Hospitalier Hutois   (Belgium)

^f UCL Mont Godinne

^g Virga Jesse Hasselt   (Belgium)

^h UNIVERSITY OF LIÈGE   (Belgium)

ⁱ St Jans Hospital   (Belgium)

^j Hospital de Jolimont   (Belgium)

^k Hopital St Joseph   (Belgium)

^l Heilige Hart Zkh   (Belgium)

^m Department of Internal Medicine   (Belgium)

ⁿ UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^o Sint Vincentiusziekenhuis   (Belgium)

^p SAINT PIERRE UNIVERSITY HOSPITAL   (Belgium)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATION; BELGIUM; GRAM NEGATIVE BACTERIUM; GRAM NEGATIVE INFECTION; HUMAN; INTENSIVE CARE; NONHUMAN;

ENTEROBACTER; ESCHERICHIA COLI; PSEUDOMONAS AERUGINOSA;

EID: 6844237004     PISSN: 00015512     EISSN: None     Source Type: Journal    
DOI: 10.1080/17843286.1998.11754138     Document Type: Article

References (31)

1. Weinstein MP, Relier LB, Murphy JR, Lichtenstein A. The clinical significance of positive blood cultures: a comprehensive analysis of 500 episodes of bacteremia and fungemia in adults. I. Laboratory and epidemiologic observations. Clin Inf Dis. 1983; 5: 35-53.
2. Pittet D. Nosocomial bloodstream infections. In: Wenzel RP, Ed. Prevention and control of nosocomial infections. Third edition. Williams and Wilkins: Baltimore. 1997; 712-69.
3. Anonymous. Hospital-acquired pneumonia in adults: diagnosis, assessment of severity, initial antimicrobial therapy, and preventive strategies. A consensus statement, American Thoracic Society, November 1995. Am J Resp Clinical Care Med. 1996; 153: 1711-25.
4. Wiblin RT. Nosocomial pneumonia. In: Wenzel RP, Ed. Prevention and control of nosocomial infections. Third edition. Williams and Wilkins: Baltimore. 1997; 808-19.
5. Centers for Disease Control. Guidelines for prevention of nosocomial pneumonia. MMWR. 1997; Vol. 46, No.RR-1: 1-79.
6. McGowan AP, Brown NM, Holt HA, Levering AM, McCulloch SY, Reeves DS. An eight-year survey of the antimicrobial susceptibility pattern of 85791 bacteria isolated from patients in a district general hospital and the local community. J Antimicrob Chemother. 1993; 31: 543-57.
7. Verbist L. Incidence of multi-resistance in Gram-negative bacterial isolates from intensive care units in Belgium: A surveillance study. Scand J Infect Dis. 1991; Suppl 78: 45-53.
8. Farmer JJ. Enterobacteriaceae. In: Murray PR, Ed. Manual of Clinical Microbiology, Sixth edition. Washington, D.C.: ASM. 1996: 438-49.
9. Gilligan PH. Pseudomonas and related genera. In: Murray PR, Ed. Manual of Clinical Microbiology, Sixth edition. Washington, D.C.: ASM. 1996: 509-19.
10. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved Standard M7-A3, Vol. 13 No 25,. NCCLS, Villanova, PA, 1993.
11. Philippon A, Labia R, Jacoby G. Extended spectrum β-lactamases. Antimicrob Agents Chemo-ther. 1989; 33: 1131-6.
12. Sirot DL, Goldstein FW, Soussy CJ, et al. Resistance to cefotaxime and seven other beta-lactams in members of the family Enterobactetiaceae: a 3-year survey in France. Antimicrob Agents Chemother. 1992; 36: 1677-81.
13. Goldstein FW, Pean Y, Rosato A, Gertner J, Gutmann L. Characterization of ceftriaxone-resistant Enterobacteriaceae: a multicentre study in 26 French hospitals. Vigil'Roc Study Group. J Antimicrob Chemother. 1993; 32: 595-603.
14. Gori A, Espinasse F, Deplano A, Nonhoff C, Nicolas MH, Struelens MJ. Comparison of pulsed-field gel electrophoresis and randomly amplified DNA polymorphism analysis for typing extended-spectrumbeta-lactamase-producing Klebsiella pneumoniae. J Clin Microbiol. 1996; 34: 2448-53.
15. Sanders CC, Sanders E Jr. Emergence of resistance during therapy with the newer beta-lactams: role of inducible beta-lactamases and implication for the future. Clin Infect Dis. 1986; 5: 639-48.
16. Sanders CC, Sanders E Jr. Type I β-lactamases of Gram-negative bacteria: interactions with β-lactam antibiotics. J Infect Dis. 1986; 154: 792-800.
17. Jarlier V, Fosse T, Phillipon, A. Antibiotic susceptibility testing in aerobic Gram-negative bacilli isolated in intensive care units in 39 French teaching hospitals (ICU study). Intensive Care Med. 1996; 22: 1057-65.
18. Tzouvelekis LS, Tzelepi E, Mentis AF, Vatopoulos AC, Tsakris A. Imipenem resistance is associated with derepression of chromosomal cephalosporinases and impaired impermeability. FEMS Microbiol Lett. 1992; 74: 195-9.
19. De Champs C, Henquell C, Guelon D, Sirot D, Gazuy N, Sirot J. Concomitant dissemination of three extended-spectrum β-lactamases amog different Enterobacteriaceae isolated in a French hospital. J Clin Microbiol. 1993; 27: 441-57.
20. Arpin C, Coze C, Rogues AM, Gachie JP, Bebear C, Quentin C. Epidemiological study of an outbreak due to multidrug-resistant Enterobacter aerogenes in a medical intensive care unit. J Clin Microbiol. 1996; 34: 2163-9.
21. Neuwirth C, Siebor E, Lopez J, Pechinot A, Kazinierezak A. Outbreak of TEM-24-producing Enterobacter aerogenes in an intensive care unit and dissemination of the extended-spectrum beta-lactamase to other members of the family enterobacteriaceae. J Clin Microbiol. 1996; 34: 76-9.
22. Buirma RJA, Horrevorts AM, Wagenwoort JHT and participants in the 1990 Dutch Surveillance Study. Scand J Infect Dis. 1991; Suppl. 78: 35-44.
23. Shah PM, Asanger R, Kahan FM. Incidence of multi-resistance in Gram-negative aerobes from intensive care units of 10 German hospitals. Scand J Infect Dis. 1991; Suppl. 78: 22-34.
24. Wust J, Auckenthaler R, Breer C, Frei R, Heinzer I, Kamm W. Antibiotic sensitivity of Gram-negative bacteria in intensive care units in Switzerland. Schweiz Med Wochenschr. 1994; 39: 1695-1700.
25. Manian FA, Meyer L, Jenne J, Owen A, Taff T. Loss of antimicrobial susceptibility in aerobic Gram-negative bacilli repeatedly isolated from patients in intensive-care units. Infect Control Hosp Epidemiol. 1996; 17: 222-6.
26. Vilain G, Ronveaux O, De Ryck R, Compère A, Trigaux F. Investigations d'infections nosocomiales à Enterobacter aerogenes dans un service de soins intensifs. Noso Info. 1997; 1: 2-8.
27. De Gheldre Y, Maes N, Rost F, De Ryck R, Clevenbergh P, Vincent JL, Struelens M. Molecular epidemiology of an outbreak of multidrug-resistant Enterobacter aerogenes infections and in vivo emergence of imipenem resistance. J Clin Microbiol. 1997; 35: 152-60.
28. Jacobson KL, Cohen SH, Inciardi JF, King JH, Lippert WE, Iglesias T, Van Couwenberghe CJ. The relationship between antecedent antibiotic use and resistance to extended-spectrum cephalosporins in group I beta-lactamase-producing organisms. Clin Infect Dis. 1995; 21: 1107-13.
29. Rijksinstittut voor Ziekte- en Invaliditeits-verzekering. Profielencommissie voor Ziekenhuis-verstrekkingen. Werkgroep Antibiotica: Informatie-campagne i.v.m. antimicrobiële middelen, 1996.
30. Gordts B, Hinderyckx M, van Landuyt HW. Het antibioticum voorschrift birmen het ziekenhuis. Tijdschrift Geneesk. 1997, 53; 41-6.
31. Janknegt R, Wijnands WJA, Caprasse M, Brandenburg W, Schuitenmaker MG, Stobberingh E. Antimicrobial drug use in hospitals in the Netherlands, Germany and Belgium. Eur J Clin Microbiol Infect Dis. 1993; 12: 832-8.